These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1674868)

  • 21. [Inhibition of insulin secretion by alpha adrenergic stimulatory agents].
    Senft G; Sitt R; Losert W; Schultz G; Hoffmann M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(4):309-23. PubMed ID: 4300750
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
    Chan SL; Mourtada M; Morgan NG
    Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre- and postsynaptic alpha-2 adrenoceptors as target for drug discovery.
    Langer SZ; Angel I
    J Neural Transm Suppl; 1991; 34():171-7. PubMed ID: 1687782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.
    Niddam R; Angel I; Bidet S; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):883-7. PubMed ID: 1975625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of alpha-2-adrenoceptors results in an increase in F-actin formation in HIT-T15 pancreatic B-cells.
    Cable HC; el-Mansoury A; Morgan NG
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):169-74. PubMed ID: 7717971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli.
    Henquin JC; Charles S; Nenquin M; Mathot F; Tamagawa T
    Diabetes; 1982 Sep; 31(9):776-83. PubMed ID: 6131003
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative study on the effects of a hypoglycemic 2-substituted-2-imidazoline derivative (DG-5128) and tolbutamide on insulin secretion from and insulin synthesis in the isolated rat pancreatic islets.
    Kameda KY; Koyama I; Abiko Y
    Biochim Biophys Acta; 1981 Oct; 677(2):263-8. PubMed ID: 7028134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors.
    Schulz A; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):321-7. PubMed ID: 2572976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic beta-cells express an imidazoline binding site that is distinct from I1 and I2 sites.
    Chan SL; Brown CA; Scarpello KE; Morgan NG
    Ann N Y Acad Sci; 1995 Jul; 763():153-6. PubMed ID: 7677324
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of phenoxybenzamine on insulin secretion from isolated rat islets of Langerhans.
    Chan SL; Morgan NG
    Biosci Rep; 1989 Apr; 9(2):223-30. PubMed ID: 2548636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats.
    Pelé-Tounian A; Chan SL; Rondu F; Le Bihan G; Giroix MH; Lamouri A; Touboul E; Pfeiffer B; Manechez D; Renard P; Guardiola-Lemaître B; Godfroid JJ; Pénicaud L; Morgan NG; Ktorza A
    Eur J Pharmacol; 1999 Jul; 377(1):81-7. PubMed ID: 10448930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin.
    Grino M; Paulmyer-Lacroix O; Faudon M; Renard M; Anglade G
    Endocrinology; 1994 Dec; 135(6):2549-57. PubMed ID: 7988443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.
    Jonas JC; Plant TD; Henquin JC
    Br J Pharmacol; 1992 Sep; 107(1):8-14. PubMed ID: 1358388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
    Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selectivity of DG-5128 as an alpha 2-adrenoceptor antagonist.
    Yamanaka K; Kigoshi S; Muramatsu I
    Eur J Pharmacol; 1984 Nov; 106(3):625-8. PubMed ID: 6151511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of imidazoline compounds on cytoplasmic Ca2+ concentration and ATP-sensitive K+ channels in pancreatic B-cells.
    Rustenbeck I; Kowalewski R; Herrmann C; Dickel C; Ratzka P; Hasselblatt A
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():42-5. PubMed ID: 8839253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the mechanism of inhibition of glucose-stimulated insulin secretion by noradrenaline in rat islets of Langerhans.
    Morgan NG; Montague W
    Biochem J; 1985 Mar; 226(2):571-6. PubMed ID: 2986600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation.
    Nakaki T; Nakadate T; Ishii K; Kato R
    J Pharmacol Exp Ther; 1981 Mar; 216(3):607-12. PubMed ID: 6110770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
    Chan SL; Atlas D; James RF; Morgan NG
    Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of efaroxan and beta-carbolines on the secretory activity of rodent and human beta cells.
    Morgan NG; Cooper EJ; Squires PE; Hills CE; Parker CA; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():167-74. PubMed ID: 15028583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.